The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-[6-(4-Aminobenzylamino)-9-isopropyl-9H-purin-2-ylamino]-butan-1-ol ID: ALA2347579
PubChem CID: 71579001
Max Phase: Preclinical
Molecular Formula: C19H27N7O
Molecular Weight: 369.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](CO)Nc1nc(NCc2ccc(N)cc2)c2ncn(C(C)C)c2n1
Standard InChI: InChI=1S/C19H27N7O/c1-4-15(10-27)23-19-24-17(21-9-13-5-7-14(20)8-6-13)16-18(25-19)26(11-22-16)12(2)3/h5-8,11-12,15,27H,4,9-10,20H2,1-3H3,(H2,21,23,24,25)/t15-/m1/s1
Standard InChI Key: CATARZWLWHJIHA-OAHLLOKOSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
20.5290 -5.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3180 -6.0957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5290 -5.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8108 -6.2585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3180 -4.7554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0968 -5.0143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0968 -5.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8108 -4.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8065 -5.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8024 -3.7743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3746 -6.2585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5769 -6.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5248 -3.3609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5164 -2.5385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6607 -5.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2328 -5.8451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0175 -7.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3827 -7.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9467 -6.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7983 -2.1376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2262 -2.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6607 -5.0184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9342 -4.6051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2179 -1.3068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7900 -1.3109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5039 -0.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5021 -0.0710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 2 0
5 3 1 0
6 7 2 0
7 4 1 0
8 3 2 0
9 2 1 0
10 8 1 0
11 7 1 0
12 2 1 0
13 10 1 0
14 13 1 0
15 11 1 0
16 19 1 0
17 12 1 0
18 12 1 0
19 15 1 0
20 14 2 0
21 14 1 0
15 22 1 1
23 22 1 0
24 21 2 0
25 20 1 0
26 24 1 0
8 6 1 0
9 5 2 0
25 26 2 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.47Molecular Weight (Monoisotopic): 369.2277AlogP: 2.78#Rotatable Bonds: 8Polar Surface Area: 113.91Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.24CX LogP: 2.06CX LogD: 2.06Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.45Np Likeness Score: -0.67
References 1. Zatloukal M, Jorda R, Gucký T, Řezníčková E, Voller J, Pospíšil T, Malínková V, Adamcová H, Kryštof V, Strnad M.. (2013) Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases., 61 [PMID:22770608 ] [10.1016/j.ejmech.2012.06.036 ]